Viewing Study NCT02202460


Ignite Creation Date: 2025-12-25 @ 2:15 AM
Ignite Modification Date: 2026-01-16 @ 3:05 PM
Study NCT ID: NCT02202460
Status: UNKNOWN
Last Update Posted: 2014-07-29
First Post: 2014-06-12
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: The Potential Biomark of Serious Psychosis:a Prospective,Case-controled Study
Sponsor: Central South University
Organization:

Study Overview

Official Title: The Potential Biomark of Serious Psychosis: Including the Variation of Brain MRI, BDNF and Oxidative Stress-related Immunological Factors in Different Phases.
Status: UNKNOWN
Status Verified Date: 2014-07
Last Known Status: NOT_YET_RECRUITING
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: Patients suffer from Serious Psychosis may have variation in immunological factors,BDNF and MRI.
Detailed Description: Patients suffer from Schizophrenia and Mood Disorders may have variation in immunological factors(TNF-α,IL-2,IL-6,IL-10,etc),BDNF and Brain MRI.

Study Oversight

Has Oversight DMC: True
Is a FDA Regulated Drug?: None
Is a FDA Regulated Device?: None
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?:

Secondary ID Infos

Secondary ID Type Domain Link View
IFMISMD REGISTRY IFMISMD View